Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01770028 · ClinicalTrials.gov registry record

Ripple Effect of Lifestyle Intervention During Pregnancy on Partners' Weight

A clinical trial of Obesity, sponsored by California Polytechnic State University-San Luis Obispo.

Completed
Registry status
122
Enrollment target
3
Study locations

NCT01770028: Completed study of Obesity, sponsored by California Polytechnic State University-San Luis Obispo.

NCT01770028 is a study of Obesity that has completed, run by California Polytechnic State University-San Luis Obispo. The registered enrollment target is 122 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01770028, a study of Obesity, has completed, sponsored by California Polytechnic State University-San Luis Obispo.

COMPLETED
Registry status
122 participants
Enrollment target
3
Study locations

Study Summary

The primary aim of the proposed study is to determine whether lifestyle interventions to prevent excessive gestational weight gain in overweight/obese pregnant women have positive "ripple" effects on untreated partners in the home. We hypothesize that partners of pregnant women randomized to the lifestyle intervention, relative to those of standard care, will have greater weight losses through 12-months. Secondary aims examine partner improvements in weight control behaviors, the home environment, and psychosocial parameters.

Primary Outcome

Change in weight of partners of pregnant women randomized to the lifestyle intervention, relative to partners of pregnant women of standard care, from 13 weeks gestation to 35 weeks gestation and 6 and 12-months postpartum.

Conditions Studied

Study Locations (3)

California

  • California Polytechnic State University - San Luis Obispo

New York

  • Columbia University - New York

Rhode Island

  • Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2013-01
Est. Completion 2017-07

What the finished NCT01770028 record still lists

NCT01770028 is an observational study that tracks outcomes without assigning an intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 0 interventions.

NCT01770028 reports a single indexed study location in California, New York, Rhode Island.

Frequently Asked Questions

What is clinical trial NCT01770028 about?

NCT01770028 is a clinical study titled "Ripple Effect of Lifestyle Intervention During Pregnancy on Partners' Weight". The primary aim of the proposed study is to determine whether lifestyle interventions to prevent excessive gestational weight gain in overweight/obese pregnant women have positive "ripple" effects on untreated partners in the home. We hypothesize that partners of pregnant women randomized to the lif...

What is the current status of trial NCT01770028?

This trial is currently completed. The enrollment target is 122 participants. The study started on 2013-01. Estimated completion is 2017-07.

What conditions does trial NCT01770028 study?

This clinical trial studies the following conditions: Obesity.

Who is sponsoring clinical trial NCT01770028?

This trial is sponsored by California Polytechnic State University-San Luis Obispo, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01770028 being conducted?

This trial has 3 study locations across California, New York, Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01770028's enrollment target sits among peer trials

122 432nd of 1053 higher than 621 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03363373 · 122 participants · Phase 2

    Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow

  • NCT03463954 · 122 participants · NA

    Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

  • NCT04503265 · 122 participants · Phase 1

    A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

  • NCT04700527 · 122 participants · Phase 1

    The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01770028, the US trial registry maintained by the National Library of Medicine. NCT01770028 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.